Rising to the global challenge of Alzheimer's Disease
Alzheimer’s disease, the most common form of dementia, can destroy memory and thinking skills as the condition progresses. Experiences, people and special moments are lost for the 44 million people with dementia worldwide. That’s one person diagnosed every four seconds.
We are facing one of the biggest global public health threats of our time. Diagnoses are on the rise with 76 million people expected to be living with dementia by 2030.
Global collaboration is needed to transform Alzheimer’s disease research and treatment.
We are committed to taking the steps needed to find a scientific breakthrough. With one of the most extensive Alzheimer’s disease research programmes in the industry, Roche is dedicated to developing more effective medicines to improve the lives of people with this devastating disease.
It won’t be easy, but doing nothing is not an option.